$4.3 B

LOXO Mkt cap, 12-Dec-2018
Loxo Oncology Net income (Q2, 2018)-15.3 M
Loxo Oncology EBIT (Q2, 2018)-20.5 M
Loxo Oncology Cash, 30-Jun-2018147.7 M

Loxo Oncology Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

R&D expense

323.0k14.0m58.3m140.0m

General and administrative expense

583.0k10.5m14.9m33.7m

Operating expense total

906.0k24.5m73.2m173.7m

EBIT

(152.4m)

Interest income

199.0k780.0k3.5m

Net Income

(10.3m)(35.9m)(72.4m)(148.9m)

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

R&D expense

2.8m3.4m8.4m12.3m14.2m20.2m24.4m64.8m32.0m73.5m

General and administrative expense

2.4m2.6m3.4m3.8m3.7m4.8m6.5m9.7m12.2m27.9m

Operating expense total

5.2m5.9m11.8m16.1m17.9m24.9m30.9m74.4m44.2m101.5m

EBIT

(5.8m)(20.5m)

Interest income

43.0k42.0k218.0k414.0k512.0k1.1m2.2m5.2m

Net Income

(8.1m)(8.8m)(11.6m)(15.9m)(17.7m)(24.5m)(30.4m)(73.3m)(3.6m)(15.3m)

Loxo Oncology Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

43.9m68.2m30.4m142.0m

Accounts Receivable

1.1b

Current Assets

107.8m156.6m141.8m781.8m

PP&E

12.0k88.0k248.0k912.0k

Total Assets

114.5m157.5m145.3m783.4m

Accounts Payable

239.0k269.0k1.1m4.0m

Current Liabilities

221.6m

Total Liabilities

15.1m405.2m

Additional Paid-in Capital

143.7m221.5m269.4m666.9m

Retained Earnings

(31.0m)(66.8m)(139.2m)(288.1m)

Total Equity

112.7m154.6m130.2m378.2m

Financial Leverage

1 x1 x1.1 x2.1 x

Loxo Oncology Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(20.7m)(35.9m)(72.4m)(148.9m)

Depreciation and Amortization

1.0k17.0k77.0k125.0k

Accounts Payable

18.0k30.0k792.0k2.9m

Cash From Operating Activities

(2.8m)(30.2m)(51.3m)107.8m

Purchases of PP&E

(14.0k)(93.0k)(237.0k)(789.0k)

Cash From Investing Activities

(69.1m)(17.2m)(26.5m)(374.2m)

Cash From Financing Activities

115.7m71.6m40.0m378.0m

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(8.1m)(8.8m)(11.6m)(15.9m)(17.7m)(24.5m)(54.9m)(128.2m)(3.6m)(15.3m)

Depreciation and Amortization

21.0k48.0k80.0k80.0k186.0k

Accounts Payable

207.0k285.0k415.0k731.0k758.0k677.0k1.0m192.0k1.1m768.0k1.8m793.0k

Cash From Operating Activities

(26.7m)(50.5m)(113.4m)109.8m74.8m

Purchases of PP&E

(101.0k)(164.0k)(398.0k)(746.0k)(2.6m)

Cash From Investing Activities

(84.7m)(96.3m)(214.0m)(148.2m)(76.3m)

Cash From Financing Activities

129.5m376.7m377.5m229.0k7.1m

Loxo Oncology Ratios

USDY, 2018

Financial Leverage

1.8 x
Report incorrect company information